CNBC's Jim Cramer said Wednesday that Eli Lilly will soon be the first pharmaceutical company to reach a $1 trillion stock market value. Shortly after the open, shares topped $1,000 each for the first time. At session highs, the stock exceeded a $950 billion market cap. Shares would have to hit nearly $1,058 to reach $1 trillion. "People are beginning to realize maybe this thing is worth far more," Cramer said during " Squawk on the Street ." He pointed to the White House's recent GLP-1 deal with Lilly and rival Novo Nordisk , which will lower prices of some of their obesity drugs for Medicare and Medicaid beneficiaries in 2026. This, in turn, will give more people access to Lilly's blockbuster weight-loss drugs. The active ingredient in Lilly's obesity treatment Zepbound, an injectable, i

See Full Page